Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "thanatophoric dysplasia"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
Condition: Hypoglycemia
Interventions: Drug: ZP4207;   Drug: GlucaGen
2 Unknown  An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP

Indicates status has not been verified in more than two years